What Is Embryo Grading and Why Does It Matter?

Embryo grading is the evaluation of an embryo's physical appearance — its cell count, symmetry, fragmentation, and structural organization — to assign a quality score.[^1] Embryologists use these scores to rank embryos from most to least likely to implant and to track each embryo’s developmental progress across the assessment days, helping decide which to transfer first, which to freeze, and which may not be clinically usable.[^1][^2]

The distinction matters. Grading assesses an embryo's appearance. It doesn't assess what it is genetically. A beautiful-looking embryo can carry chromosomal abnormalities, and a less-than-perfect one can be completely normal.[^1][^3] That's a critical nuance — and one that comes up again when we discuss genetic testing later in this article.

Does grading actually predict outcomes? Yes — but imperfectly. A 2022 retrospective evaluation of over 4,000 embryos confirmed that higher morphological scores are associated with better clinical outcomes, including higher implantation and pregnancy rates.[^4] The relationship is consistent enough that every IVF lab in the world uses some form of grading. But it's probabilistic, not deterministic. A grade tells you odds, not destiny.

Key Insight:
Embryo grading tells you what an embryo looks like under a microscope — not whether it's chromosomally normal. A top-grade embryo can be aneuploid, and a low-grade embryo can be euploid.[^1][^3]

→ Learn more: In Vitro Fertilization (IVF)

How Are Embryos Graded From Day 0 to Transfer?

Embryo assessment isn't a single event — it's a series of checkpoints over 5 to 6 days — and, at some clinics, up to Day 7, which marks the final cut-off.[^1] Each stage reveals different information about the embryo's developmental potential. The 2025 ESHRE/ALPHA Istanbul Consensus update provides the most current international framework for these assessments.[^1]

What Happens at the Fertilization Check (Day 0)?

About 16–18 hours after insemination or ICSI, embryologists check whether fertilization has occurred.[^1][^5] Normal fertilization is confirmed by the presence of two pronuclei (2PN) — one from the egg, one from the sperm — and two polar bodies.[^1] This is the first quality filter.

Oocytes showing one pronucleus (1PN) or three or more (3PN) are typically excluded from clinical use because they're associated with abnormal chromosome numbers.[^1][^5] A 2013 systematic review found that pronuclear morphology can provide some information about subsequent embryo quality, but it isn't a strong standalone predictor of implantation.[^5][^6] Think of the fertilization check as a pass/fail gate rather than a grading step — it confirms that the basics went right.

Note:
Labs occasionally see a 2PN zygote with one small extra pronucleus — a “2.1PN” zygote. These are rare, but a meaningful share turn out to be chromosomally normal (biparental diploid) and can produce healthy live births, so they may be worth using — especially alongside PGT-A — even though their developmental potential tends to be lower.[^1]

How Are Day 2 and Day 3 Embryos Graded?

By Day 3 (approximately 68 hours after insemination), a normally developing embryo should contain 6–10 cells.[^1][^2] Embryologists assess three main features at this stage: cell count, fragmentation, and symmetry.[^1][^5]

Cell count is the most informative Day 3 parameter. In a study of 33,999 Day 3 embryos, those with fewer than 6 cells were 81% less likely to develop into a blastocyst compared to embryos with 6–10 cells.[^7] Embryos with more than 10 cells were slightly more likely to reach the blastocyst stage.[^7]

Fragmentation refers to small membrane-bound pieces that break off during cell division. The 2025 Istanbul Consensus update categorizes fragmentation into four grades[^1]:

Sources: 2025 ESHRE/ALPHA Istanbul Consensus update;[^1] Elkhatib et al. (2025)[^7]

Compared to grade A fragmentation, embryos with grade B had 56% lower odds of reaching the blastocyst stage, grade C had 79% lower odds, and grade D had 88% lower odds.[^7]

Blastomere symmetry (whether cells are roughly equal in size) is also assessed, although the 2025 consensus notes that the predictive value of symmetry alone is less well established than that of cell count or fragmentation.[^1]

Here's what's worth knowing about fragmentation specifically: a heavily fragmented Day 3 embryo is less likely to reach the blastocyst stage, but if it does reach the blastocyst stage, its chances of being chromosomally normal are about the same as a low-fragmentation embryo.[^7] The fragmentation is more of a developmental speed bump than a genetic red flag.

Note:
In clinical practice, every case is individual. Embryologists regularly see heavily fragmented Day 3 embryos go on to form beautiful blastocysts. Fragmentation shifts the odds; it doesn’t decide the outcome for any single embryo.

What Happens on Day 4?

On Day 4, the embryo transitions from a collection of individual cells into a compacted structure called a morula. During compaction, cells form tight junctions with one another and begin to communicate — the first step toward differentiating into the tissues that will become the fetus and the placenta.[^1][^8]

The stage at which compaction begins appears to matter. A 2023 study of 1,194 embryos found that embryos compacting from more than 8 cells had significantly better blastocyst quality than those compacting earlier.[^8] Compaction from fewer than 8 cells barely produced blastocysts suitable for transfer.[^8]

Day 4 assessment is increasingly recognized as a useful checkpoint rather than a waiting room for Day 5. A 2024 retrospective study comparing Day 4 morula transfer with Day 5 blastocyst transfer found no significant difference in clinical pregnancy rate, miscarriage rate, or live birth rate between the two approaches.[^9]

How Are Blastocysts Graded on Day 5 and Day 6?

By Day 5, a developing embryo should reach the blastocyst stage — a hollow sphere containing two distinct cell types: the inner cell mass (ICM), which develops into the fetus, and the trophectoderm (TE), which forms the placenta.[^1][^10] This is where the familiar letter-number grading system comes in.

The most widely used system is the Gardner classification, which evaluates three components[^1][^10]:

Source: Gardner and Schoolcraft (1999) as described in the 2025 ESHRE/ALPHA Istanbul Consensus update[^1]

So when your clinic writes "4BB", they're saying: expansion stage 4 (expanded), ICM grade B (loosely grouped but present), and TE grade B (fewer cells with some gaps). That's a solid, transferable blastocyst.

A common misconception: grade B isn't a bad grade. In the Gardner system, grade A is excellent, grade B is good, and grade C is poor but still potentially viable. Most transferred blastocysts worldwide are grade B in at least one component.

Note:
Some clinics use minor variations on the Gardner scale. When the inner cell mass or trophectoderm sits between two grades, you may see a notation like “4BBc” — meaning the inner cell mass is good (B), and the trophectoderm falls between good and poor (B/C).

What Do the Grades Actually Mean for Success Rates?

Grades are associated with live birth rates, but the association is weaker than most patients assume. A 2023 multinational study of 10,964 single blastocyst transfers across 14 clinics in three countries provides the clearest picture[^11]:

Source: Zou et al. (2023), multinational multicentre observational study of 10,964 single blastocyst transfers[^11]

These figures come from morphologically graded (not genetically tested) blastocysts in a cohort with a mean maternal age of about 33, and they vary considerably with age. In the same study, the predicted live birth rate after a low-grade transfer was roughly 40% for women aged 25, but only about 19–23% for women aged 35 and older.[^11]

Two things stand out. First, even low-grade blastocysts have a 30% live-birth rate — roughly 1 in 3. Second, the gap between good and moderate grades is smaller than most people expect (44% versus 39%).[^11]

Which Blastocyst Component Matters Most?

Not all parts of the grade carry equal weight. A 2024 retrospective study of 1,546 frozen single blastocyst transfers found that trophectoderm (TE) grade was the strongest predictor of live birth — more predictive than ICM or expansion status.[^10] When the TE grade dropped from A to C, the live birth rate fell from 37.9% to 18.3%.[^10]

An unexpected finding: blastocysts graded BA (ICM-B, TE-A) had a significantly higher live birth rate than those graded AB (ICM-A, TE-B) — 40.9% versus 32.1%.[^10] If you had to choose between a better inner cell mass and a better trophectoderm, the data suggests the trophectoderm matters more. This makes biological sense. Implantation is a trophectoderm-driven process: TE cells attach to the uterine lining, establish the maternal-fetal interface, and subsequently form the placenta. Inner cell mass quality shapes fetal development — but none of that can begin until the trophectoderm has successfully implanted.[^10]

Bottom Line:
Blastocyst grade predicts live birth, but not as strongly as most patients think. A BB blastocyst still has a nearly 40% live-birth rate. Of all grade components, trophectoderm quality is the most predictive.[^10][^11]

Are Poor-Quality Embryos Still Worth Transferring?

Yes — and the evidence here is reassuring. Low-grade blastocysts implant less often, but once a pregnancy is established, miscarriage and live birth rates are not significantly different from those of good-grade embryos.[^11][^12][^13]

The Zou et al. multinational study confirmed this directly: after adjusting for confounders, there was no significant difference in pregnancy loss between low- and good-grade blastocysts (adjusted odds ratio, 0.97; 95% CI, 0.76–1.22).[^11] A 2020 Canadian center reported appreciable live birth rates from transfers of lower-quality embryos, making a strong argument for freezing grade C blastocysts rather than discarding them — especially for patients with limited embryo cohorts.[^13]

What about the babies? A 2023 study examining obstetric outcomes and placental findings found subtle biological differences across pregnancies with different embryo grades, but the clinical outcomes — birth weight, gestational age, and neonatal health — were comparable.[^14] The perinatal data from the Zou study supports this: preterm birth rates, birthweight Z-scores, and rates of low or high birth weight were not significantly different between low-grade and good-grade blastocysts.[^11]

One more question patients ask: should you transfer a poor-quality embryo alongside a good one? A 2022 systematic review and meta-analysis found that adding a poor-quality embryo to a good one doesn't improve outcomes compared to transferring the good one alone — but the poor embryo doesn't sabotage the good one either.[^15]

Important:
Don't assume a low-grade embryo means a low chance of a healthy baby. If it implants, outcomes are comparable to those from higher-grade embryos.[^11][^12][^13] Ask your clinic about their policy on freezing lower-grade blastocysts.

Does Genetic Testing Change What Grades Mean?

Preimplantation genetic testing for aneuploidy (PGT-A) answers a fundamentally different question than grading. The grading question is: Does this embryo look normal? PGT-A asks: Does this embryo have the correct number of chromosomes?[^16][^17]

The relationship between the two is loose. A 2024 prospective cohort study found that morphology is a proxy for chromosomal status only about half the time — a good-looking embryo has roughly a coin-flip chance of being euploid, and a poor-looking one can be perfectly normal.[^18] Appearance alone cannot replace genetic testing.

Here's the critical finding: once you know an embryo is euploid, its grade matters much less. A 2020 study found that PGT-A testing largely flattens the morphology signal — among confirmed euploid embryos, morphological grade was no longer a reliable predictor of live birth.[^16] A 2025 retrospective study of PGT-A cycles reinforced this, finding that once euploidy was confirmed, none of the morphological features reliably predicted live birth in frozen embryo transfer.[^19]

Does that mean grades are useless if you're doing PGT-A? Not entirely. One study found that among euploid blastocysts, ICM grade retained some predictive value — embryos with better ICM quality still showed a trend toward higher live birth rates.[^17] Morphology still adds something, but the contribution becomes much smaller when genetic status is already known.

The 2024 ASRM committee opinion states that morphology-based selection remains the standard for most patients and that PGT-A adds value in specific scenarios — including recurrent pregnancy loss, recurrent implantation failure, and advanced maternal age.[^20]

→ Learn more: Pre-implantation Genetic Testing (PGT)

Why Might Your Grade Differ Between Clinics?

Embryo grading is subjective. Two embryologists looking at the same embryo can assign different grades — and this variability increases significantly when comparing embryologists from different clinics.[^3]

A 2022 study coordinated by the Italian Society of Embryology, Reproduction and Research (SIERR) asked embryologists from 18 IVF centers to grade the same set of embryo photographs using the Istanbul Consensus criteria.[^3] The results were revealing: intra-center reliability (agreement between senior and junior embryologists within the same clinic) was moderate to substantial, with Cohen's kappa values of 0.56–0.72 depending on the parameter.[^3] But inter-center reliability — agreement between different clinics — was only fair (kappa 0.21–0.40).[^3]

What does this mean for you? A "4BB" at one clinic might be scored as a "3BC" or "4AB" at another. This doesn’t mean one clinic is wrong — it means the grading system has inherent limitations. Never directly compare grades between clinics as if they were standardized test scores.

Can Artificial Intelligence Reduce This Variability?

Potentially, yes. A 2020 study using deep neural networks for embryo assessment found that AI-based grading was more consistent than grading by individual embryologists, reducing inter-observer variability.[^21] A 2024 survey-based study found that AI-assisted ranking particularly benefited embryologists with 5 years or less of experience, likely because they were more willing to trust the algorithm's recommendations.[^22]

But AI isn't replacing embryologists yet. A 2023 review emphasized that the human experience and clinical judgment remain essential — an embryologist considers contextual information (patient history, culture conditions, clinic-specific patterns) that current AI systems don't incorporate.[^23] The most promising approach combines both: AI as a decision-support tool with the embryologist making the final call.[^21][^22][^23]

So, What Should You Do Now?

Understanding embryo grading helps you interpret your clinic's reports and have more informed conversations with your care team. Here's how to put this knowledge into action.

Step 1: Ask Your Clinic to Explain Your Grades

Request a clear explanation of the grading system your clinic uses. Ask specifically what each component of your embryo's grade means — expansion, ICM, and TE — and how your embryos compare to the range they typically see.

Step 2: Understand the Grading System Your Clinic Uses

Not all clinics use the Gardner system. Some use the ESHRE/ALPHA Istanbul Consensus criteria, some use modified versions, and some have internal scoring systems. Ask whether their grades translate to the standard A/B/C framework discussed in this article.

Step 3: Don't Dismiss Lower-Grade Embryos

If your clinic has frozen lower-grade blastocysts, don't write them off. Low-grade embryos produce live births — and once implanted, pregnancy outcomes are comparable to those from higher-grade embryos. Discuss the viability of all your frozen embryos with your embryologist.

Step 4: Ask About PGT-A If Appropriate

If you're over 38, have experienced recurrent miscarriage, or have had repeated implantation failure, discuss whether preimplantation genetic testing might add value to your embryo selection process. PGT-A can provide information that grading alone cannot.

Step 5: Compare Clinics Using Standardized Outcomes, Not Grades

When evaluating fertility clinics, compare their reported success rates — live birth rates per transfer and cumulative live birth rates per cycle — rather than comparing embryo grades across centers. MedicalNavigator.com makes this comparison straightforward.

→ Learn more: What to Do Before Embryo Transfer

→ Compare fertility clinics worldwide: MedicalNavigator.com/fertility-clinics

Too Long, Didn’t Read

• Embryo grading evaluates appearance — cell count, fragmentation, and structure — not genetic health.

• The ideal Day 3 embryo has 6–10 cells with less than 10% fragmentation.

• Blastocyst grades combine three scores: expansion (1–6), inner cell mass (A–C), and trophectoderm (A–C).

• Good-grade blastocysts have a 44% live birth rate and low-grade still achieve 30%, though rates vary with maternal age and other factors.

• Once implanted, pregnancy outcomes from low-grade embryos are comparable to those from high-grade.

• Grades vary between clinics — inter-centre agreement is only fair, so never compare grades across centres.

References